Related Experiment Video
Updated: Jun 6, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Persistent placoid maculopathy imaged with spectral domain OCT and autofluorescence
1Bascom Palmer Eye Institute at Naples, University of Miami School of Medicine, 311 9th St. North, Naples, FL 34102, USA. jkovach@med.miami.edu
Summary
Persistent placoid maculopathy involves white lesions in the macula. Prompt immunosuppression may preserve vision and delay complications like choroidal neovascularization.
Area of Science:
- Ophthalmology
- Medical Retina
- Immunosuppression Therapy
Background:
- Persistent placoid maculopathy (PPM) is a rare condition.
- Characterized by bilateral, well-delineated whitish plaque-like lesions in the macula.
- Associated with potential for vision loss due to secondary complications.
Observation:
- Spectral domain optical coherence tomography (SD-OCT) and autofluorescence imaging reveal extensive retinal pigment epithelial damage.
- These imaging modalities are crucial for assessing the extent of PPM.
- Secondary choroidal neovascularization (CNV) is a common complication.
Findings:
- Aggressive immunosuppression demonstrates potential to preserve visual acuity in PPM patients.
- Early intervention with immunosuppressive agents may delay the onset of CNV.
- The underlying mechanisms linking PPM and CNV require further investigation.
Implications:
- Aggressive immunosuppression represents a promising therapeutic strategy for managing PPM.
- Preserving vision and delaying CNV onset are key goals in PPM treatment.
- Further research into PPM pathogenesis could lead to novel therapeutic targets.
